Covaxin safe, shows 77.8% efficacy against symptomatic COVID-19: Lancet study

zeebiz.com - Two doses of Covaxin, India's indigenous COVID-19 vaccine, offer 77.8 per cent protection against symptomatic disease and present no serious safety concerns Get more India News and Business News on Z…

Tweeted by @nishant1amity https://twitter.com/nishant1amity/status/1459577951574380544